Latest filing published 03 Apr 2024 for Ventyx Biosciences, Inc., €8,285.
Filing timeline
BuySaleInsider track record
Christopher W. Krueger: trading record in brief
Christopher W. Krueger has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Ventyx Biosciences, Inc. and Intrabiotics Pharmaceuticals Inc /DE. In total, 67 filings cover trades dated from 19 May 2009 to 2 April 2024.
The open-market record consists of 39 sales worth €7.2M, with no purchase. Outside the open market, there are 28 option exercises. In 2024 alone, the filings show no purchases and 1 sale.
The latest filing, published on 3 April 2024, reports an open-market sale of €8,285 in Ventyx Biosciences, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Christopher W. Krueger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,651 shares@ US$5.40360.3% of flowCommon StockSEC:0001415889-24-010183:0
- 4,531 shares0Common StockSEC:0001415889-24-009458:0
- 5,293 shares@ US$2.11790.3% of flowCommon StockSEC:0001209191-23-059500:0
- 10,479 shares0Common StockSEC:0001209191-23-059228:0
- 14,006 shares@ US$29.936.2% of flowCommon StockSEC:0001209191-23-052128:1
- 994 shares@ US$30.700.5% of flowCommon StockSEC:0001209191-23-052128:2
- 15,000 shares@ US$8.043.8% of flowCommon StockSEC:0001209191-23-052128:0
- 10,431 shares@ US$32.254.9% of flowCommon StockSEC:0001209191-23-048623:1
- 4,546 shares@ US$33.422.2% of flowCommon StockSEC:0001209191-23-048623:2
- 23 shares@ US$33.970.0% of flowCommon StockSEC:0001209191-23-048623:3
- 15,000 shares@ US$8.043.7% of flowCommon StockSEC:0001209191-23-048623:0
- 13,300 shares@ US$35.556.7% of flowCommon StockSEC:0001209191-23-044664:1
- 1,700 shares@ US$35.910.9% of flowCommon StockSEC:0001209191-23-044664:2
- 15,000 shares@ US$8.043.6% of flowCommon StockSEC:0001209191-23-044664:0
- 13,911 shares@ US$0.200.0% of flowCommon StockSEC:0001209191-23-041353:1
- 403 shares@ US$33.56710.2% of flowCommon StockSEC:0001209191-23-041353:2
- 214 shares@ US$34.7220.1% of flowCommon StockSEC:0001209191-23-041353:3
- 40 shares@ US$35.4970.0% of flowCommon StockSEC:0001209191-23-041353:4
- 1,960 shares@ US$38.04771.1% of flowCommon StockSEC:0001209191-23-041353:5
- 2,150 shares@ US$38.79031.2% of flowCommon StockSEC:0001209191-23-041353:6
- 10,233 shares@ US$39.87035.8% of flowCommon StockSEC:0001209191-23-041353:7
- 1,089 shares@ US$8.040.3% of flowCommon StockSEC:0001209191-23-041353:0
- 10,284 shares@ US$0.200.0% of flowCommon StockSEC:0001209191-23-034885:1
- 12,883 shares@ US$34.31056.4% of flowCommon StockSEC:0001209191-23-034885:2
- 2,117 shares@ US$34.65121.1% of flowCommon StockSEC:0001209191-23-034885:3
25 of 67 declarations
